Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
---|---|---|---|---|---|---|---|---|
2024-04-11 | NEVRO CORP | GROSSMAN D KEITH
(Director) |
F | Common Stock | D | 3986 | $13.12 - $13.12 | $52,296 |
2024-04-04 | NEVRO CORP | Rashid Kashif
(SVP, Corp Dev and CLO) |
F | Common Stock | D | 479 | $13.21 - $13.21 | $6,327 |
2024-03-31 | NEVRO CORP | Kosaraju Sridhar
(Director) |
A | Common Stock | A | 1090 | $0.00 - $0.00 | $0 |
2024-03-31 | NEVRO CORP | DEMANE MICHAEL F
(Director) |
A | Common Stock | A | 1817 | $0.00 - $0.00 | $0 |
2024-03-31 | NEVRO CORP | WEATHERMAN ELIZAB...
(Director) |
A | Common Stock | A | 1372 | $0.00 - $0.00 | $0 |
2024-03-31 | NEVRO CORP | Fischer Frank M
(Director) |
A | Common Stock | A | 1159 | $0.00 - $0.00 | $0 |
2024-03-11 | NEVRO CORP | GROSSMAN D KEITH
(Director) |
F | Common Stock | D | 2184 | $14.99 - $14.99 | $32,738 |
2024-03-07 | NEVRO CORP | Thornal Kevin R
(President & CEO) |
A | Common Stock | A | 150581 | $0.00 - $0.00 | $0 |
2024-03-07 | NEVRO CORP | Carter Richard B.
(Chief Accounting Officer) |
F | Common Stock | D | 2706 | $15.32 - $15.32 | $41,455 |
2024-03-07 | NEVRO CORP | Carter Richard B.
(Chief Accounting Officer) |
A | Common Stock | A | 16866 | $0.00 - $0.00 | $0 |
2024-03-04 | NEVRO CORP | GROSSMAN D KEITH
(Director) |
F | Common Stock | D | 1597 | $14.51 - $14.51 | $23,172 |
2024-03-04 | NEVRO CORP | GROSSMAN D KEITH
(Director) |
A | Common Stock | A | 4750 | $0.00 - $0.00 | $0 |
2024-03-04 | NEVRO CORP | MacLeod Roderick H.
(Chief Financial Officer) |
F | Common Stock | D | 438 | $14.51 - $14.51 | $6,355 |
2024-03-04 | NEVRO CORP | MacLeod Roderick H.
(Chief Financial Officer) |
A | Common Stock | A | 743 | $0.00 - $0.00 | $0 |
2024-03-04 | NEVRO CORP | Carter Richard B.
(Chief Accounting Officer) |
F | Common Stock | D | 125 | $14.51 - $14.51 | $1,813 |
2024-03-04 | NEVRO CORP | Carter Richard B.
(Chief Accounting Officer) |
A | Common Stock | A | 212 | $0.00 - $0.00 | $0 |
2024-03-04 | NEVRO CORP | Rashid Kashif
(General Counsel) |
F | Common Stock | D | 425 | $14.51 - $14.51 | $6,166 |
2024-03-04 | NEVRO CORP | Rashid Kashif
(General Counsel) |
A | Common Stock | A | 743 | $0.00 - $0.00 | $0 |
2024-03-01 | NEVRO CORP | Carter Richard B.
(Chief Accounting Officer) |
F | Common Stock | D | 825 | $14.22 - $14.22 | $11,731 |
2024-03-03 | NEVRO CORP | GROSSMAN D KEITH
(Director) |
F | Common Stock | D | 1403 | $14.22 - $14.22 | $19,950 |
2024-02-28 | NEVRO CORP | MacLeod Roderick H.
(Chief Financial Officer) |
F | Common Stock | D | 898 | $14.82 - $14.82 | $13,308 |
2024-02-28 | NEVRO CORP | Rashid Kashif
(General Counsel) |
F | Common Stock | D | 898 | $14.82 - $14.82 | $13,308 |
2024-01-04 | NEVRO CORP | Rashid Kashif
(General Counsel) |
F | Common Stock | D | 526 | $19.39 - $19.39 | $10,199 |
2023-12-31 | NEVRO CORP | WEATHERMAN ELIZAB...
(Director) |
A | Common Stock | A | 920 | $0.00 - $0.00 | $0 |
2023-11-11 | NEVRO CORP | Carter Richard B.
(Chief Accounting Officer) |
F | Common Stock | D | 230 | $15.04 - $15.04 | $3,459 |
A | Grant, award or other acquisition |
C | Conversion of Derivative or Security |
D | Disposition to the issuer of issuer equity securities |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability |
G | Bona fide Gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary Transaction |
J | Other acquisition or disposition |
K | Transaction in equity swap or instrument with similar characteristics |
L | Small Acquisition |
M | Exercise or conversion of derivative security |
O | Exercise of out-of-the-money derivative security |
P | Open Market Purchase |
S | Open Market Sale |
U | Disposition pursuant to a tender of shares in a change of control transaction |
V | Transaction Voluntarily Reported |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |